title: Dopa-responsive hemiparkinsonism due to midbrain Virchow-Robin spaces?
authors.forename: Martin
authors.initials: M
authors.lastname: Krause
authors.forename: Stefan
authors.initials: S
authors.lastname: Hähnel
authors.forename: Uwe
authors.initials: U
authors.lastname: Haberkorn
authors.forename: Hans-Michael
authors.initials: HM
authors.lastname: Meinck
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D005260:Female; D007839:Functional Laterality; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008636:Mesencephalon / Q000000981:diagnostic imaging / Q000473:pathology*; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000188:drug therapy*; D013346:Subarachnoid Space / Q000000981:diagnostic imaging / Q000187:drug effects*; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa